Is it worth screening for vancomycin-resistant Enterococcus faecium colonization?: Financial burden of screening in a developing country

American Journal of Infection Control

Volumn 44, Issue 4, 2016, Pages e45-e49

  Ulu Kilic, Aysegul ^a   Özhan, Esra ^a   Altun, Dilek ^a   Perçin, Duygu ^a   Güneş, Tamer ^a   Alp, Emine ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

colonization; Enterococcus faecium; pediatrics; Vancomycin resistance

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BLOODSTREAM INFECTION; CASE CONTROL STUDY; CHILD; CONTACT ISOLATION; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; FEMALE; HEALTH CARE COST; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SCREENING; TURKEY (REPUBLIC); URINARY TRACT INFECTION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS INFECTION; ADOLESCENT; COST; CRITICAL ILLNESS; DEVELOPING COUNTRY; ECONOMICS; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HETEROZYGOTE; INFECTION CONTROL; ISOLATION AND PURIFICATION; MASS SCREENING; MICROBIOLOGY; NEWBORN; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY; TURKEY;

ADOLESCENT; CARRIER STATE; CHILD; CHILD, PRESCHOOL; COSTS AND COST ANALYSIS; CRITICAL ILLNESS; DEVELOPING COUNTRIES; ENTEROCOCCUS FAECIUM; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTION CONTROL; MALE; MASS SCREENING; RETROSPECTIVE STUDIES; TURKEY; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84952890175     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2015.11.008     Document Type: Article

References (13)

1. 1 Muto, C.A., Giannetta, E.T., Durbin, L.J., Simonton, B.M., Farr, B.M., Cost-effectiveness of perirectal surveillance cultures for controlling vancomycin-resistant Enterococcus. Infect Control Hosp Epidemiol 23 (2002), 429–435.
2. 2 Lloyd-Smith, P., Younger, J., Lloyd-Smith, E., Green, H., Leung, V., Romney, M.G., Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay. J Hosp Infect 85 (2013), 54–59.
3. 3 Popiel, K.Y., Miller, M.A., Evaluation of vancomycin-resistant enterococci (VRE)-associated morbidity following relaxation of VRE screening and isolation precautions in a tertiary care hospital. Infect Control Hosp Epidemiol 35 (2014), 818–825.
4. 4 Bouchillon, S.K., Johnson, B.M., Hoban, D.J., Johnson, J.L., Dowzicky, M.J., Wu, D.H., et al. Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int J Antimicrob Agents 24 (2004), 119–124.
5. 5 Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. CLSI document (M100-S23). 2013, National Committee for Clinical Laboratory Standards, Wayne (PA).
6. 6 Milstone, A.M., Maragakis, L.L., Carroll, K.C., Perl, T.M., Targeted surveillance to identify children colonized with vancomycin-resistant Enterococcus in the pediatric intensive care unit. Infect Control Hosp Epidemiol 31 (2010), 95–98.
7. 7 Nateghian, A., Robinson, J.L., Arjmandi, K., Vosough, P., Karimi, A., Behzad, A., et al. Epidemiology of vancomycin-resistant enterococci in children with acute lymphoblastic leukemia at two referral centers in Tehran, Iran: a descriptive study. Int J Infect Dis 15 (2011), e332–5.
8. 8 von Baum, H., Schehl, J., Geiss, H.K., Schaefer, F., Prevalence of vancomycin-resistant enterococci among children with end-stage renal failure. Mid-European Pediatric Peritoneal Dialysis Study Group. Clin Infect Dis 29 (1999), 912–916.
9. 9 Weddle, G., Jackson, M.A., Selvarangan, R., Utility of a focused vancomycin-resistant enterococci screening protocol to identify colonization in hospitalized children. Am J Infect Control 40 (2012), 891–892.
10. 10 Kara, A., Devrim, I., Bayram, N., Katipoglu, N., Kiran, E., Oruc, Y., et al. Risk of vancomycin-resistant enterococci bloodstream infection among patients colonized with vancomycin-resistant enterococci. Braz J Infect Dis 19 (2015), 58–61.
11. 11 DiazGranados, C.A., Zimmer, S.M., Klein, M., Jernigan, J.A., Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis. Clin Infect Dis 41 (2005), 327–333.
12. 12 Furuno, J.P., McGregor, J.C., Harris, A.D., Johnson, J.A., Johnson, J.K., Langenberg, P., et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 166 (2006), 580–585.
13. 13 Baden, L.R., Thiemke, W., Skolnik, A., Chambers, R., Strymish, J., Gold, H.S., et al. Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of “clearance”. Clin Infect Dis 33 (2001), 1654–1660.